Biohaven (BHVN) Non Operating Income (2021 - 2026)
Biohaven's (BHVN) quarterly Non Operating Income came in at $168000.0 in Q1 2026, down 65.92% year-on-year from $493000.0 in Q1 2025, and up 106.8% quarter-over-quarter from -$2.5 million in Q4 2025.
Biohaven (BHVN) Non Operating Income (2021 - 2026) Analysis & Trends
Biohaven has disclosed Non Operating Income across 6 years of filings, most recently posting $168000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $168000.0, down 65.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (down 78.45% YoY), and the FY2025 annual result was $8.0 million, down 79.71% from the prior year.
- Non Operating Income came in at $168000.0 for Q1 2026 at Biohaven, up from -$2.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $17.8 million in Q3 2024 to a low of -$3.8 million in Q3 2025.
- The 5-year median for Non Operating Income is $3.7 million (2024), against an average of $4.5 million.
- Across the five-year window, Non Operating Income sank 226.41% in 2022 and soared 205825.0% in 2023, its largest moves.
- Biohaven's Non Operating Income stood at -$1.8 million in 2022, then soared by 521.27% to $7.7 million in 2023, then sank by 59.5% to $3.1 million in 2024, then sank by 178.76% to -$2.5 million in 2025, then soared by 106.8% to $168000.0 in 2026.
- The last three Non Operating Income figures came in at $168000.0 (Q1 2026), -$2.5 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | -2.47 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | 13.82 Mn |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 17.81 Mn |
| Jun 30, 2024 | 14.18 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 8.23 Mn |
| Dec 31, 2022 | -1.84 Mn |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | -5,000.00 |